Bullish
Relay Therapeutics launches $175M public stock offering
Relay Therapeutics has announced a public stock offering aiming to raise $175 million. The biotechnology company is looking to secure additional capit...
Relay Therapeutics has announced a public stock offering aiming to raise $175 million. The biotechnology company is looking to secure additional capit...
This article provides an overview of Relay Therapeutics Inc (RLAY), a biotechnology company specializing in small molecule therapies for cancer and ge...